Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability
Hee Ju Cho, Tag Keun Yoo Department of Urology, Eulji Hospital, Eulji University School of Medicine, Seoul, KoreaAbstract: α1-Adrenergic receptor antagonists are commonly used to treat male lower urinary tract symptoms and benign prostatic hyperplasia (BPH). We performed a literature sear...
Main Authors: | Cho HJ, Yoo TK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Research and Reports in Urology |
Online Access: | http://www.dovepress.com/silodosin-for-the-treatment-of-clinical-benign-prostatic-hyperplasia-s-peer-reviewed-article-RRU |
Similar Items
-
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
by: Yoshida M, et al.
Published: (2011-06-01) -
Silodosin in the treatment of benign prostatic hyperplasia
by: Maxime Rossi, et al.
Published: (2010-10-01) -
Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia
by: Sakata Koichi, et al.
Published: (2012-10-01) -
The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study
by: Young Won Kim, et al.
Published: (2015-09-01) -
Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study
by: Kazuhisa Hagiwara, et al.
Published: (2016-01-01)